Elkins David V 4
Research Summary
AI-generated summary
Bristol Myers (BMY) CFO David Elkins Receives Award, Withholds Shares
What Happened
- David V. Elkins, Chief Financial Officer of Bristol Myers Squibb (BMY), reported vesting/conversion of equity awards on March 10, 2026. Aggregate conversions/awards credited approximately 151,145 shares (combination of market share units, performance share units and other award conversions).
- To satisfy withholding and exercise-related obligations, 16,114 shares were withheld/disposed at an indicated share value of $60.13, representing roughly $968,935 in tax/exercise-related value. Several other small dispositions/adjustments (24,999 shares) are reported with no cash value shown in the filing.
- These transactions reflect award vesting/conversion and tax-withholding (routine compensation events), not an open-market purchase or discretionary sell order.
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely filing).
- Price used for tax/withholding lines: $60.13 per share; total withholding value reported ≈ $968,935.
- Shares reported credited (approx): 151,145 (from exercises/conversions and grants). Shares withheld/disposed for taxes/exercise: 16,114. Other reported dispositions/adjustments: 24,999 shares (no cash shown).
- Filing includes footnotes explaining: vesting of quarterly tranches (F1, F4), performance-adjusted payout factors for market share units (F2, F8, F10), tax-withholding (F3), and distribution timing/certification for performance shares (F5, F9, F11, F12).
- Exhibit: Power of Attorney (Exhibit 24).
- Amount of securities owned following the reported transactions is not provided in the excerpted data.
Context
- This appears to be routine compensation vesting/conversion and associated tax withholding (shares retained to cover tax/exercise obligations), not an open-market sale or buy. For derivatives/performance awards: payout and final share conversion may be subject to performance factors and board certification per footnotes. Routine withholding is common and does not necessarily indicate the insider’s view on the stock.